Back
Pharming Group Vs. Stride Industry Stock Comparison
Sell
42
PHAR
Pharming Group
Last Price:
8.12
Seasonality Move:
16.96%
Buy
76
LRN
Stride
Last Price:
92.29
Seasonality Move:
-4.21%
Sell
42
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $8.30. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
76
Stride (LRN)
is a Buy
Is Stride a Buy, Sell or Hold?
- The current Stride [LRN] share price is $92.33. The Score for LRN is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- LRN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $8.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing slight buying pressure.
PHAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 47.8 | Sell |
Chaikin Money Flow: | 2550 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.95 - 8.83) | Sell |
Bollinger Bands (100): | (7.59 - 8.63) | Buy |
LRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.83 | Sell |
Relative Strength Index (14 RSI): | 70.18 | Buy |
Chaikin Money Flow: | 2060084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.34 - 86.78) | Buy |
Bollinger Bands (100): | (68.67 - 82.15) | Buy |
PHAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.77 | Sell |
20-day SMA: | 8.56 | Sell |
50-day SMA: | 8.02 | Buy |
200-day SMA: | 9.54 | Sell |
8-day EMA: | 8.71 | Sell |
20-day EMA: | 8.52 | Sell |
50-day EMA: | 8.26 | Buy |
200-day EMA: | 9.2 | Sell |
LRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.7 | Buy |
20-day SMA: | 77 | Buy |
50-day SMA: | 79.84 | Buy |
200-day SMA: | 69.08 | Buy |
8-day EMA: | 77.22 | Buy |
20-day EMA: | 76.69 | Buy |
50-day EMA: | 77.52 | Buy |
200-day EMA: | 69.64 | Buy |
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
Stride Earnings Growth & LRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $2.19 per share.
Pharming Group Technical Analysis
Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Stride Technical Analysis
Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |